Therapy News and Research

RSS

NCPA, NACDS explain importance of pharmacies in Medicaid program

The National Association of Chain Drug Stores and the National Community Pharmacists Association have sent a joint letter to every Governor and State Medicaid Director, explaining the importance of pharmacies in Medicaid, offering recommendations, and expressing a desire to work together to cut costs without endangering Medicaid beneficiaries' access to pharmacy prescription drug services.

21 Feb 2011

Proper wound care may treat skin infections effectively than antibiotics in children with MRSA

When it comes to curing skin infected with the antibiotic-resistant bacterium MRSA, timely and proper wound cleaning and draining may be more important than the choice of antibiotic, according to a new Johns Hopkins Children's Center study. The work is published in the March issue of Pediatrics.

21 Feb 2011

New research: Reovirus infected melanoma cells secrete proteins that can kill cancer

Reoviruses are successfully being used in clinical trials to treat patients with cancer. Not only does the virus cause cancer cells to die, it also forces them to release pro-inflammatory chemokines and cytokines, which in turn causes the patient's immune system to attack the disease.

21 Feb 2011

New diagnostic tool to detect patients with active TB disease

Tuberculosis remains one of the most pressing public health priorities for the 21st century, with over one third of the world population infected. Active TB disease is a major issue both for the patients who require specific treatment and at a population level, since these patients are contagious.

21 Feb 2011

New blood pressure measurement device may enable doctors to treat patients more effectively

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients' blood pressure is measured.

20 Feb 2011

New study shows low doses of aspirin can significantly reduce risk of cancers

A new study by scientists from Oxford, Edinburgh, London and Japan shows that at low doses, aspirin can significantly reduce the risk of a range of cancers.

20 Feb 2011

Chronic fatigue syndrome – eased by psychotherapy: Study

New British research suggests that people with chronic fatigue syndrome may be helped the most when standard treatment is coupled with cognitive behaviour therapy or exercise therapy.

20 Feb 2011

Largest Medicare fraud case nets 114 offenders

In one of the largest healthcare fraud cases, the U.S. government last Thursday charged 114 doctors, nurses and other defendants with Medicare crime schemes that exceeded $225 million in false billings.

20 Feb 2011

In the Gulf states rates of heart disease are rising with the economy

Rapid improvement in the socio-economic conditions of the Gulf states has been followed by lifestyle changes now contributing to high rates of cardiovascular disease. Professor Hani Najm, President of the Saudi Heart Association whose annual conference begins 21 February 2011, describes risk factor prevalence rates as "extremely high", particularly in the cities of Saudi Arabia.

20 Feb 2011

Treating depression: A vital step in cancer recovery

With all of the stresses of today’s modern world, depression is unfortunately becoming a common household word for many people in this country and abroad. During the cold winter months, many also struggle with seasonal depression or “winter blues,” known as Seasonal Affective Disorder (SAD). Depression can be caused by any number of factors, such as chronic stress, inactivity, hormone or neurotransmitter imbalances, nutritional deficiencies, medication side effects, chronic inflammation, or lack of adequate sunshine exposure, among others.

20 Feb 2011

CompanDX, CRL enter multi-year agreement to develop biomarker panels

CompanDX Ltd., bioinformatics partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL), provider of laboratory testing services in molecular diagnostics and clinical trials, today announced they entered into a multi-year agreement to collaborate in the development and support of biomarker panels and companion diagnostic development for pharmaceutical, biotech and academic clients worldwide.

19 Feb 2011

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Protalix BioTherapeutics, Inc., announced today that new clinical data from the switchover trial of taliglucerase alfa in Gaucher disease patients and preclinical data on oral enzyme glucocerebrosidase (oral GCD) will be presented today at the 7th Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2011 in Las Vegas, Nevada.

19 Feb 2011

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation today announced three-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate. Sustained or further improvements were observed across all endpoints, including bone disease, at the three-year timepoint.

19 Feb 2011

PBMI awards CVS Caremark and ArcelorMittal the 2011 Rx Benefit Innovation Award

CVS Caremark announced today that the Pharmacy Benefit Management Institute (PBMI) awarded the company and its PBM client ArcelorMittal, the world's largest steel company, the 2011 Rx Benefit Innovation Award. The award recognizes the Pharmacy Advisor program, which was developed by CVS Caremark to manage costs, improve medication adherence and close gaps in care for members with diabetes.

19 Feb 2011

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

Bellicum Pharmaceuticals, Inc. today announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the 2011 Genitourinary Cancers Symposium held in Orlando, Florida on February 17 – 19, 2011.

19 Feb 2011

Author provides tips to combat symptoms of seasonal affective disorder

Winter's chill, dark days, devoid of sunshine can send the best of us spiraling into a bad case of the blues. But those dreary winter months - particularly, February - can debilitate people living with depression.

19 Feb 2011

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Australian health care company Prima BioMed Ltd announced today that there has been an agreement for strategy and design of the Phase III clinical registration trial for the CVac™ immunotherapy therapeutic ovarian cancer vaccine.

19 Feb 2011

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

A new study has identified factors that predict the ability of a professional dancer to return to professional performance after hip arthroscopy surgery. The study by Hospital for Special Surgery investigators will be presented at the American Academy of Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San Diego, Calif.

19 Feb 2011

Deep brain stimulation therapy promising against severe OCD

When obsessive-compulsive disorder is of crippling severity and drugs and behavior therapy can't help, there has been for just over a year a thread - or rather a wire - of hope. By inserting a thin electrode deep into the brain, doctors can precisely deliver an electrical current to a cord of the brain's wiring and soften the severity of the symptoms. "Deep brain stimulation" therapy for OCD won Food and Drug Administration approval in 2009 for extreme cases under its humanitarian device exemption.

19 Feb 2011

Positive results from Medtronic CoreValve System study for treatment of aortic valve disease

Medtronic, Inc. today issued a statement on results from an independent study published online in the journal Circulation, which confirmed both early and sustained clinical benefits for patients receiving the Medtronic CoreValve® System for the treatment of aortic valve disease.

19 Feb 2011

Therapy News and Research

NCPA, NACDS explain importance of pharmacies in Medicaid program

Proper wound care may treat skin infections effectively than antibiotics in children with MRSA

New research: Reovirus infected melanoma cells secrete proteins that can kill cancer

New diagnostic tool to detect patients with active TB disease

New blood pressure measurement device may enable doctors to treat patients more effectively

New study shows low doses of aspirin can significantly reduce risk of cancers

Chronic fatigue syndrome – eased by psychotherapy: Study

Largest Medicare fraud case nets 114 offenders

In the Gulf states rates of heart disease are rising with the economy

Treating depression: A vital step in cancer recovery

CompanDX, CRL enter multi-year agreement to develop biomarker panels

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

PBMI awards CVS Caremark and ArcelorMittal the 2011 Rx Benefit Innovation Award

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

Author provides tips to combat symptoms of seasonal affective disorder

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

Deep brain stimulation therapy promising against severe OCD

Positive results from Medtronic CoreValve System study for treatment of aortic valve disease

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News